We have previously demonstrated in primary cancer of the uterine cervi
x that tumor hypoxia, as determined polarographically, is strongly ass
ociated with clinical malignant progression of the disease, Having app
lied a similar methodological approach to investigate loco-regional re
lapses, we found a pronounced shift to more hypoxic oxygenation profil
es in the recurrent tumors than in the primary tumors. Median pO(2) va
lues in 53 pelvic recurrences were significantly lower than the median
pO(2) values of 117 primary tumors of comparable sizes (7.1 +/- 1.1 m
mHg vs. 12.1 +/- 1.0 mmHg, p = 0.0013), The differences in tumor oxyge
nation between primary and recurrent tumors mirrored the differences i
n the patients' 5-year survival probabilities. In the cohort of patien
ts with pelvic relapses, median tumor pO(2) < 4 mmHg indicated a signi
ficantly shorter median survival time as compared to median tumor pO(2
) greater than or equal to 4 mmHg, Our results further support our the
sis that in cervical cancer, tumor hypoxia and clinical aggressiveness
in terms of resistance to therapy and tumor dissemination, are interr
elated. Int. J. Cancer (Pred. Oncol.) 79:365-369, 1998. (C) 1998 Wiley
-Liss, Inc.